Research article · 30 Jul 2026
Conference abstractPublished 14 Nov 2016
Metastatic melanoma: An unusual presentation
St. Vincent’s Hospital, Australia; Campbelltown Hospital, Australia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
An 89-year-old female presented with an eighteen-month history of a large, protuberant, nontender left groin mass measuring 15Ã?Â?8 cms. There were numerous melanocytic nevi present on her chest and abdomen. Past medical history was unremarkable. Computed Tomography (CT) of the pelvis showed a heterogeneously enhancing well circumscribed complex mass in the subcutaneous tissue with mixed solid and cystic components. Core biopsy was performed and histopathological analysis revealed scattered dissociated malignant cells with enlarged, eccentric nuclei and unevenly distributed chromatin, consistent with metastatic melanoma. A staging CT revealed bilateral lower lobe pulmonary metastasis with left hilar lymphadenopathy. The primary site of the melanoma remains to be established. The patient declined any treatment and died within six months of diagnosis. The incidence of malignant melanoma is rising with majority of the cases being detected when the disease is curable. However a small proportion of cases present with metastatic disease at time of diagnosis and carry a poor prognosis. The 10-year survival rate for patients with metastatic melanoma is known to be less than 10%. Although any organ can be involved, common sites for metastases include the liver, bone and brain. Cutaneous metastases are a frequent event in the progression of melanoma seen both in the early and late phases of disease. The site of metastasis is an important independent predictor of survival; patients with distal nodal and soft tissue metastases have a better survival than patients with visceral metastasis. Systemic therapy is the cornerstone of treatment for metastatic melanoma. Palliative surgery or radiotherapy to metastatic sites is generally performed to relieve symptoms secondary to tumor growth. In summary, melanoma is a potentially fatal form of skin cancer and early detection is crucial to improve survival and decrease mortality.
Subjects
DermatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical & Experimental Dermatology Research.
Commentary · 30 Jul 2026
Breaking the Stigma Around Psoriasis: A Broader View of Chronic Skin Disease
Perspective · 28 Jul 2026
Acne as More Than a Cosmetic Concern: A Personal and Medical Perspective
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Dermatology Research
- SubjectDermatology
- BylineArticles whose byline prints “Pooja Kadam”
- BylineArticles whose byline prints “Ankur Krishna”

